KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Income from Continuing Operations (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Income from Continuing Operations for 17 consecutive years, with 1776000000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 80.76% to 1776000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6524000000.0 through Dec 2025, down 51.32% year-over-year, with the annual reading at 6524000000.0 for FY2025, 51.32% down from the prior year.
  • Income from Continuing Operations hit 1776000000.0 in Q4 2025 for Abbott Laboratories, up from 1644000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 9229000000.0 in Q4 2024 to a low of 1033000000.0 in Q4 2022.
  • Historically, Income from Continuing Operations has averaged 1982650000.0 across 5 years, with a median of 1619000000.0 in 2023.
  • Biggest five-year swings in Income from Continuing Operations: soared 478.98% in 2024 and later crashed 80.76% in 2025.
  • Year by year, Income from Continuing Operations stood at 1989000000.0 in 2021, then crashed by 48.06% to 1033000000.0 in 2022, then soared by 54.31% to 1594000000.0 in 2023, then skyrocketed by 478.98% to 9229000000.0 in 2024, then plummeted by 80.76% to 1776000000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for ABT at 1776000000.0 in Q4 2025, 1644000000.0 in Q3 2025, and 1779000000.0 in Q2 2025.